Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer

PURPOSE: Combining targeted agents with adjuvant chemotherapy prolongs survival in human epidermal growth factor receptor 2 (HER2)-positive breast cancer patients, but also increases the risk of adverse effects. The updated results of 3 randomized controlled trials (RCTs) were reported in 2019. Give...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinyan, Yao, Litong, Wang, Mozhi, Wang, Mengshen, Li, Xiang, Yu, Xueting, Guo, Jingyi, Dong, Haoran, Sun, Xiangyu, Xu, Yingying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462812/
https://www.ncbi.nlm.nih.gov/pubmed/32908791
http://dx.doi.org/10.4048/jbc.2020.23.e45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462812/
https://www.ncbi.nlm.nih.gov/pubmed/32908791
http://dx.doi.org/10.4048/jbc.2020.23.e45

Ejemplares similares